Urgent call for update of COVID vaccines as cases increase at almost record levels

Vaccines Against COVID must be urgently updated to target new variants, as the level of infection in the United Kingdom rises to almost record levels, leading scientists have warned. On average, 28,000 and 507 people are infected with viruses every day in the United Kingdom, according to the latest data from the ZOE Study [...]
Vaccines Against COVID must be urgently updated to target new variants, as the level of infection in the United Kingdom rises to almost record levels, leading scientists have warned.
On average, 28,000 and 507 people are infected with viruses every day in the United Kingdom, according to the latest data from the ZOE COVID Study. Professor Tim Spector said the cases were soon expected to exceed 300 thousand.
With Britain now in its fifth wave, and admission into the hospital once again increasing, scientists argue that a specific new vaccine for Omitron can offer better protection against future variants, helping to reduce cases, Klankosova explains. tv
Professor John Edmunds, an epidemiologist and member of the Scientific Emergency Consultative Group (Sage), said that the results of a recent study of a vaccine two in a specific for the original COVID virus and the Omitron variant were encouraging.
Protection against infection and hospitalization by Omitron decreases within months after a third dose. After a backlog, effectiveness in hospital prevention decreases from 91.6 percent to 72.5 percent over 10 weeks, according to government analysis.
The fourth doses are already being distributed into specific groups, including the elderly, with another reinforceee to be offered in the autumn, but experts believe it is time to update vaccines in hopes of providing broader and longer-term protection against variants.
The data released last week by Moderna showed that her needle used by the ébivalente offers good protection against Omitron, which lasts more than the original vaccine. It also increases immunity to sub-vaitarians Omitron BA.4 and BA.5, which are promoting actual growth in cases in Britain.
Professor David Robertson, head of bio-informatics at the University of Glasgow Centre for Virus Research, said a updated provider of Omitron's specific vaccine should be made available for all.












